×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ARTL – artelo biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ARTL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
8/9
08:10 am
artl
Artelo Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
High
Report
Artelo Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
7/19
09:07 am
artl
Artelo Biosciences Completes Enrollment of the First Three Cohorts in its CAReS Study Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Low
Report
Artelo Biosciences Completes Enrollment of the First Three Cohorts in its CAReS Study Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
6/27
08:30 am
artl
Artelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain
Medium
Report
Artelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain
6/24
08:40 am
artl
Artelo Biosciences Selected For Oral Presentation At The 32nd Annual ICRS Symposium In Galway, Ireland [TheStreet.com]
Low
Report
Artelo Biosciences Selected For Oral Presentation At The 32nd Annual ICRS Symposium In Galway, Ireland [TheStreet.com]
6/24
08:30 am
artl
Artelo Biosciences Selected for Oral Presentation at the 32nd Annual ICRS Symposium in Galway, Ireland
Low
Report
Artelo Biosciences Selected for Oral Presentation at the 32nd Annual ICRS Symposium in Galway, Ireland
6/1
09:22 am
artl
Artelo Biosciences To Present At The LD Micro Invitational XII On June 7th [TheStreet.com]
Low
Report
Artelo Biosciences To Present At The LD Micro Invitational XII On June 7th [TheStreet.com]
6/1
08:30 am
artl
Artelo Biosciences to Present at the LD Micro Invitational XII on June 7th
Low
Report
Artelo Biosciences to Present at the LD Micro Invitational XII on June 7th
5/16
09:00 am
artl
Artelo Biosciences To Present At The H.C. Wainwright Global Investment Conference On May 24th [TheStreet.com]
Low
Report
Artelo Biosciences To Present At The H.C. Wainwright Global Investment Conference On May 24th [TheStreet.com]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
8/9
08:06 am
artl
Form 8-K ARTELO BIOSCIENCES, INC. For: Aug 08
High
Report
Form 8-K ARTELO BIOSCIENCES, INC. For: Aug 08
8/9
08:01 am
artl
Form 10-Q ARTELO BIOSCIENCES, INC. For: Jun 30
High
Report
Form 10-Q ARTELO BIOSCIENCES, INC. For: Jun 30
7/12
04:16 pm
artl
Form 8-K ARTELO BIOSCIENCES, INC. For: Jun 24
Medium
Report
Form 8-K ARTELO BIOSCIENCES, INC. For: Jun 24
6/27
05:21 pm
artl
Form 4 ARTELO BIOSCIENCES, INC. For: Jun 24 Filed by: MATSUI CONNIE
Medium
Report
Form 4 ARTELO BIOSCIENCES, INC. For: Jun 24 Filed by: MATSUI CONNIE
6/27
05:20 pm
artl
Form 4 ARTELO BIOSCIENCES, INC. For: Jun 24 Filed by: EMANUELE ROBERT MARTIN
Medium
Report
Form 4 ARTELO BIOSCIENCES, INC. For: Jun 24 Filed by: EMANUELE ROBERT MARTIN
6/27
05:19 pm
artl
Form 4 ARTELO BIOSCIENCES, INC. For: Jun 24 Filed by: Kelly Steven
Medium
Report
Form 4 ARTELO BIOSCIENCES, INC. For: Jun 24 Filed by: Kelly Steven
6/27
05:18 pm
artl
Form 4 ARTELO BIOSCIENCES, INC. For: Jun 24 Filed by: Reyes Gregory
Medium
Report
Form 4 ARTELO BIOSCIENCES, INC. For: Jun 24 Filed by: Reyes Gregory
6/27
05:18 pm
artl
Form 4 ARTELO BIOSCIENCES, INC. For: Jun 24 Filed by: SEYMOUR TAMARA A
Medium
Report
Form 4 ARTELO BIOSCIENCES, INC. For: Jun 24 Filed by: SEYMOUR TAMARA A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
6/21
Form EFFECT ARTELO BIOSCIENCES, INC.
284.3%
4/14 Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update 31.4%
2/3 Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program 23.3%
7/9 Artelo Biosciences (NASDAQ: ARTL) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. 20.1%
6/20 Form S-1/A ARTELO BIOSCIENCES, INC. 15.2%
11/1 Form 4 ARTELO BIOSCIENCES, INC. For: Oct 30 Filed by: Gorgas Gregory D. 9.2%
3/23 Artelo Biosciences to Present at the Spring Investor Summit on March 25th 8.8%
9/11 Artelo Biosciences to Present at the Fall Investor Summit in New York City on September 17th 7.3%
8/30 Form 4 ARTELO BIOSCIENCES, INC. For: Aug 29 Filed by: MATSUI CONNIE 7.2%
6/25 Form 8-K ARTELO BIOSCIENCES, INC. For: Jun 21 6.5%
4/14 Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update 31.4%
2/3 Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program 23.3%
7/9 Artelo Biosciences (NASDAQ: ARTL) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. 20.1%
6/20 Form S-1/A ARTELO BIOSCIENCES, INC. 15.2%
11/1 Form 4 ARTELO BIOSCIENCES, INC. For: Oct 30 Filed by: Gorgas Gregory D. 9.2%
3/23 Artelo Biosciences to Present at the Spring Investor Summit on March 25th 8.8%
9/11 Artelo Biosciences to Present at the Fall Investor Summit in New York City on September 17th 7.3%
8/30 Form 4 ARTELO BIOSCIENCES, INC. For: Aug 29 Filed by: MATSUI CONNIE 7.2%
6/25 Form 8-K ARTELO BIOSCIENCES, INC. For: Jun 21 6.5%
TOP News Decliners
10/17
Form 4 ARTELO BIOSCIENCES, INC. For: Oct 15 Filed by: Gorgas Gregory D.
-21.0%
3/11 Form 8-K ARTELO BIOSCIENCES, INC. For: Mar 06 -15.9%
11/25 Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update -15.9%
6/10 Form S-1/A ARTELO BIOSCIENCES, INC. -15.4%
4/15 Form 8-K ARTELO BIOSCIENCES, INC. For: Apr 13 -14.0%
1/15 Form S-3 ARTELO BIOSCIENCES, INC. -13.6%
2/4 Form EFFECT ARTELO BIOSCIENCES, INC. -12.0%
2/14 Form SC 13G ARTELO BIOSCIENCES, INC. Filed by: Moss David J -10.6%
10/30 Form S-3 ARTELO BIOSCIENCES, INC. -9.1%
2/3 Artelo's [MarketWatch] -8.9%
3/11 Form 8-K ARTELO BIOSCIENCES, INC. For: Mar 06 -15.9%
11/25 Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update -15.9%
6/10 Form S-1/A ARTELO BIOSCIENCES, INC. -15.4%
4/15 Form 8-K ARTELO BIOSCIENCES, INC. For: Apr 13 -14.0%
1/15 Form S-3 ARTELO BIOSCIENCES, INC. -13.6%
2/4 Form EFFECT ARTELO BIOSCIENCES, INC. -12.0%
2/14 Form SC 13G ARTELO BIOSCIENCES, INC. Filed by: Moss David J -10.6%
10/30 Form S-3 ARTELO BIOSCIENCES, INC. -9.1%
2/3 Artelo's [MarketWatch] -8.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: